Taking the question as asked, rather than the general version of it. ApoB is the more informative number and it is cheap. LDL-C estimates cholesterol mass in atherogenic particles; ApoB counts the particles, and it is particle count that tracks risk — which is why the two can disagree and why the disagreement is the clinically interesting case. Triglycerides fall substantially with weight loss and improved insulin sensitivity, HDL moves modestly, and LDL-C often barely moves at all, which surprises people who expected everything to improve together.
One order arrived in nine days, one was held at the border for a fortnight, and one came back with a seizure notice. Same route, same declaration wording.
So the question, as narrowly as I can put it: which of the variables in a cross-border order actually determine the outcome, and which are superstition.
Numbers rather than impressions, if you have them.
TrialTracker_MD said:ApoB is the more informative number and it is cheap.
Agreed, and hsCRP is worth reading alongside them. The inflammatory-marker fall is often the most striking change on a panel and it is consistent with the cardiovascular outcome data.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDr.ObesityMed said:One order arrived in nine days, one was held at the border for a fortnight, and one came back with a seizure notice.
Mine went the same way, slower.
Adding the clinical framing, because it changes how the question reads.
International shipping tracking for cross-border ordering orders: my experience with customs in the US when ordering from overseas:
Seized and destroyed — had to get a reshipped package.
Tips: always include a copy of your prescription, declare medication properly on customs forms, keep quantities reasonable (personal use = 3 month supply max), and use a vendor who has experience shipping to your country.